Latest filing published 31 Mar 2022 for Karyopharm Therapeutics Inc..
Filing timeline
BuySaleInsider track record
Sharon Shacham: trading record in brief
All filings by Sharon Shacham on record concern Karyopharm Therapeutics Inc., in the capacity of senior executive. Between 12 November 2013 and 29 March 2022, the trades on record add up to 156 filings.
Every open-market trade on record is a sale: 80 sales worth €16.7M. Outside the open market, there are 4 share grants and 68 option exercises. So far in 2022, the count stands at no purchases and 6 sales.
The newest entry dates from 31 March 2022: a share grant, in Karyopharm Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sharon Shacham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 60,000 shares0Common StockSEC:0001209191-22-021755:0
- 21,000 shares0Common StockSEC:0001209191-22-014626:1
- 6,226 shares@ US$10.24Common StockSEC:0001209191-22-014626:2
- 6,226 shares@ US$10.237526.9% of flowCommon StockSEC:0001209191-22-014626:0
- 9,079 shares@ US$12.12Common StockSEC:0001209191-22-011639:1
- 9,088 shares@ US$12.123445.8% of flowCommon StockSEC:0001209191-22-011639:0
- 6,764 shares@ US$9.86Common StockSEC:0001209191-22-008119:1
- 6,707 shares@ US$9.86227.3% of flowCommon StockSEC:0001209191-22-008119:0
- 4,000 shares@ US$12.39Common StockSEC:0001209191-21-022487:0
- 57,200 shares0Common StockSEC:0001209191-21-015482:1
- 57,200 shares0Common StockSEC:0001209191-21-015482:0
- 9,495 shares@ US$14.83Common StockSEC:0001209191-21-012964:0
- 6,642 shares@ US$15.52Common StockSEC:0001209191-21-011486:0
- 21,800 sharesCommon StockSEC:0001209191-21-011486:1
- 6,601 shares@ US$15.52Common StockSEC:0001209191-21-011486:2
- 21,800 sharesCommon StockSEC:0001209191-21-011486:3
- 14,300 sharesCommon StockSEC:0001209191-21-009073:0
- 14,300 sharesCommon StockSEC:0001209191-21-009073:1
- 1,424 shares@ US$0.0330.0% of flowCommon StockSEC:0001209191-20-054821:0
- 6,076 shares@ US$0.0330.0% of flowCommon StockSEC:0001209191-20-054821:1
- 7,500 shares@ US$14.891Common StockSEC:0001209191-20-054821:2
- 1,477 shares@ US$0.0330.0% of flowCommon StockSEC:0001209191-20-047278:0
- 1,477 shares@ US$15.00Common StockSEC:0001209191-20-047278:1
- 7,500 shares@ US$0.0330.0% of flowCommon StockSEC:0001209191-20-042840:0
- 7,500 shares@ US$19.4297Common StockSEC:0001209191-20-042840:1
25 of 143 declarations
